Navigation Links
SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Monthly Subcutaneous Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis
Date:6/26/2009

, ankles, feet, lower back and neck are commonly affected. Psoriasis affects an estimated two to three percent of the world's population, and approximately one out of three patients affected by psoriasis may develop psoriatic arthritis. Both men and women are equally affected by psoriatic arthritis, most commonly between the ages of 30 and 50, in the peak of their productive years.

About Ankylosing Spondylitis

Ankylosing spondylitis is a painful and progressive form of spinal arthritis, and symptoms of inflammatory back pain often first present in people under the age of 35 years. On the European continent, it is estimated that prevalence ranges from 0.2 to one percent of the entire population. It typically begins in the late teens and early 20s, and in severe cases can result in fusing of the spinal vertebrae and cause structural damage to hips and other joints. Often misdiagnosed as "just back pain" or undifferentiated arthritis, AS is a systemic inflammatory disease that, in addition to its effect on the spine, can affect internal organs, peripheral joints and vision.

About SIMPONI

SIMPONI is a human monoclonal antibody that targets and neutralizes excess TNF alpha, a protein that when overproduced in the body due to chronic inflammatory diseases can cause inflammation and damage to bones, cartilage and tissue. Upon approval in the European Union, SIMPONI will be the first once-monthly subcutaneous anti-TNF-alpha therapy for the treatment of moderate-to-severe, active RA, active and progressive PsA and severe, active AS, and will be available either through the SIMPONI SmartJect(TM) auto injector or a prefilled syringe. The approved dose for SIMPONI in the US and Canada is a 50 mg subcutaneous injection given once a month.

Important Safety Information

In Europe, SIMPONI is contraindicated in patients with active tuberculosis, severe infections such as sepsis, oppo
'/>"/>

SOURCE Schering-Plough Corporation; Centocor Ortho Biotech Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. New Analysis Shows Efficacy of SIMPONI(TM) (golimumab) in Anti-TNF Experienced Rheumatoid Arthritis Patients
2. Two-Year Data Show Patients Receiving SIMPONI(TM) (golimumab) Experienced Sustained Improvement in Signs and Symptoms of Psoriatic Arthritis and Ankylosing Spondylitis
3. Transave Receives $2.2 Million Cystic Fibrosis Foundation Award for Development of ARIKACE(TM)
4. Cepheid Receives Grant to Develop Ten-Color Real-Time PCR Detection Technology for Use in the GeneXpert(R) System
5. DOR BioPharma Receives EMEA Agreement on the Design of its Confirmatory Phase 3 Clinical Trial of orBec(R) in GI GVHD
6. Malaria Vaccine Developer, Sanaria Inc., Receives 2009 Vaccine Industry Excellence Award for Best Early-Stage Vaccine Biotech
7. NeurogesX Receives FDA Orphan Drug Designation for Qutenza(TM) for Treatment of Postherpetic Neuralgia
8. AMT Receives EMEA Orphan Drug Designation for Acute Intermittent Porphyria
9. Terumo Heart, Inc. Reaches Clinical Milestone as the 100th Patient Worldwide Receives the DuraHeart(TM) Left Ventricular Assist System
10. Agennix Receives Fast Track Designation From FDA for Talactoferrin in Combination With Sunitinib for Renal Cell Carcinoma
11. Pelleve Receives FDA Clearance for the Treatment of Mild to Moderate Facial Wrinkles
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/28/2015)... BETHESDA, Md. , May 28, 2015 /PRNewswire-USNewswire/ ... that it will be a supporting organization of ... assurance and sterilization in 2016. Johnson ... a series of high-profile superbug infections in endoscopes. ... world health issues between 1976 and 2003 on ...
(Date:5/28/2015)... , May 28, 2015 Compassion & Choices today ... approved a bill that would authorize the option of medical ... 5-2. The ... , would allow mentally competent adults with six months or ... could take to painlessly and peacefully end an unbearable dying ...
(Date:5/28/2015)... 28, 2015 Research ... addition of Jain PharmaBiotech,s new report  "Personalized ... their offering.  ,     (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , ,The ... is to match the right drug to ... even to design the appropriate treatment for ...
Breaking Medicine Technology:PDA Announces Support for the Johnson & Johnson Kilmer Conference 2California Committee Sends Medical Aid-in-Dying Bill to Senate Floor 2California Committee Sends Medical Aid-in-Dying Bill to Senate Floor 3Global Personalized Medicine Report 2015-2024 - Scientific and Commercial Aspects 2Global Personalized Medicine Report 2015-2024 - Scientific and Commercial Aspects 3
... Dey Pharma, L.P., a subsidiary of Mylan Inc. (Nasdaq: ... Food Allergy Awareness Week (FAAW), May 8-14. Created by the ... to educate others and raise awareness about food allergies, a ... are the most common trigger of anaphylaxis,(3) a severe allergic ...
... Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: ... radiotherapy and diagnostic imaging centers in China, today announced that ... The Company will present at the 16th CLSA ... 2011 at the Grand Hyatt Hotel in Beijing. Management will ...
Cached Medicine Technology:Dey Pharma Commemorates 14th Annual Food Allergy Awareness Week 2Dey Pharma Commemorates 14th Annual Food Allergy Awareness Week 3Dey Pharma Commemorates 14th Annual Food Allergy Awareness Week 4Dey Pharma Commemorates 14th Annual Food Allergy Awareness Week 5Dey Pharma Commemorates 14th Annual Food Allergy Awareness Week 6Concord Medical Services Holdings to Present at Two Upcoming Conferences 2
(Date:5/29/2015)... The Bill Howe Family of Companies is ... air conditioning and restoration & flood services company. Family-owned and ... commitment to giving back to their community. They have been ... row from the Union Tribune Reader’s Poll, a Healthiest Company ... multi-year recognition as a Best Place to Work as well ...
(Date:5/29/2015)... May 28th, TheCelebrityDresses.com released their new range of exclusively ... of the styles in their new collection were priced ... styles of sexy cocktail dresses and 100 cheap bridesmaid ... with the new release are color blocks, exclusively designed ... the new styles are made of carefully selected fine ...
(Date:5/28/2015)... Recently, KORT Richmond, 5006 Atwood Drive, added a ... of life. The program works with those new to prosthetic ... but are still having difficulty. , According to the ... with limb loss in the United States. The main causes ... peripheral arterial disease – trauma (45%) and cancer (less than ...
(Date:5/28/2015)... 28, 2015 Today the National Resident ... for the 2015 Main Residency Match®. A record-number ... were filled when the matching algorithm was processed. ... during the Match Week Supplemental Offer and Acceptance Program® ... are pleased with the outcome of the 2015 Main ...
(Date:5/28/2015)... AMVETS National Executive Director Stewart Hickey ... Care established by Congress to examine how to best ... to the commission by Mitch McConnell, majority leader of ... only 15 voting members on the panel, which was ... of 2014. The goal of the commission is to ...
Breaking Medicine News(10 mins):Health News:Bill Howe Plumbing Business Development Director Honored for Contribution to Woman in Industry 2Health News:Bill Howe Plumbing Business Development Director Honored for Contribution to Woman in Industry 3Health News:TheCelebrityDresses.com Released New Collection of Cheap Bridesmaid and Party Dresses 2Health News:KORT Richmond Physical Therapy Adds New Program to Help Amputees 2Health News:NRMP Releases Results and Data: 2015 Residency Match: Record Number of Positions Filled 2Health News:NRMP Releases Results and Data: 2015 Residency Match: Record Number of Positions Filled 3Health News:AMVETS Executive Director Stewart Hickey Appointed to Congressional Commission on Care 2
... a study published recently in the journal Science ... on the molecular level how the anti-malaria drug chloroquine ... strategies for treating inflammation and a multitude of autoimmune ... Chloroquine is a widely used anti-malaria drug that ...
... School of Medicine have identified how a gene for a ... nerve cells in the brain, thereby contributing to Alzheimer,s disease. ... (Abeta) in the brain. Abeta plays a key role in ... to Alzheimer,s disease and identified where the molecules lived in ...
... institute aimed at accelerating the pace of translating science ... from the National Institutes of Health to expand its ... Clinical and Translational Science Institute (CTSI) is among 10 ... of their successes during the first five years of ...
... money that hospitals spend on environmental services, such as ... influencing patient satisfaction scores as the way the money ... focusing on improving the efficiency of operations, hospitals can ... out of the financial investments they make toward support ...
... with older people with no signs of Alzheimer,s, those whose brains ... experience a fall, researchers have found. In the new study, ... participating in a study of memory and aging. The seniors were ... over the course of eight months. An increased risk of ...
... NFL football players are at higher risk for mild cognitive ... Loyola University Health System study has found. , A screening ... 35 percent of the players had scores suggesting possible mild ... appears there may be a very high rate of cognitive ...
Cached Medicine News:Health News:Chloroquine finding may lead to treatments for arthritis, cancer and other diseases 2Health News:Chloroquine finding may lead to treatments for arthritis, cancer and other diseases 3Health News:Researchers identify how a gene linked to both Alzheimer's disease and type 2 diabetes works 2Health News:UCSF receives $112 million to help translate science into cures 2Health News:UCSF receives $112 million to help translate science into cures 3Health News:UCSF receives $112 million to help translate science into cures 4Health News:Value of hospital environmental services linked to efficiency not expenses 2Health News:Value of hospital environmental services linked to efficiency not expenses 3Health News:Falls Could Signal Early Alzheimer's Disease 2Health News:Retired NFL players at higher risk for mild cognitive impairment 2
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: